SCHEMBL14545929

SCHEMBL14545929

COc1cc(C2CCN(C)C2)nc2c(Br)cnn12

nearest known ligand 0.43

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ CDK2 P24941 3/20 0.43
▸ CHEK1 O14757 2/20 0.43
▸ CCNA2 P20248 2/20 0.43
▸ CCNA1 P78396 2/20 0.43
▸ GSK3B P49841 5/20 0.37
▸ TLR7 Q9NYK1 2/20 0.33
▸ HTR1A P08908 1/20 0.32
▸ HTR1D P28221 1/20 0.32
▸ HTR1B P28222 1/20 0.32
▸ HTR2A P28223 1/20 0.32
▸ HTR2C P28335 1/20 0.32
▸ HTR1E P28566 1/20 0.32
▸ HTR7 P34969 1/20 0.32
▸ HTR2B P41595 1/20 0.32
▸ HTR3A P46098 1/20 0.32
▸ HTR5A P47898 1/20 0.32
▸ CNR2 P34972 1/20 0.31
▸ CCNT1 O60563 1/20 0.31
▸ CDK9 P50750 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14545936 0.83 LRRK2 (0.36) CDK2CHEK1CCNA2CCNA1GSK3B
SCHEMBL14413501 0.82 CHEK1 (0.41) CDK2CHEK1CCNA2CCNA1GSK3B
SCHEMBL14545930 0.81 CHEK1 (0.34) CDK2CHEK1CCNA2CCNA1GSK3B
SCHEMBL14050983 0.79 PDE4B (0.43) CDK2CHEK1CCNA2CCNA1
SCHEMBL11930869 0.78 CHEK1 (0.61) CDK2CHEK1CCNA2CCNA1GSK3B
SCHEMBL14542953 0.77 CHEK1 (0.73) CDK2CHEK1CCNA2CCNA1GSK3B
SCHEMBL11931324 0.76 TRPV3 (0.42) CDK2CHEK1CCNA2CCNA1
SCHEMBL14413493 0.72 CHEK1 (0.32) CDK2CHEK1CCNA2CCNA1
SCHEMBL10460653 0.70 GSK3B (0.49) CDK2CHEK1CCNA2CCNA1GSK3B
SCHEMBL14413496 0.70 CHEK1 (0.34) CDK2CHEK1CCNA2CCNA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007044449-A2 NOVEL PYRAZOLOPYRIMIDINES AS CYCLIN DEPENDENT KINASE INHIBITORS SCHERING CORPORATION (US) 2007-04-19 — — WO disclosed
Send feedback